Francis Berenbaum

Francis Berenbaum serves as the French representative of the European COST action NetwOArk and currently holds positions as Chair of the Scientific Advisory Board at 4P-Pharma and 공동 CEO at 4Moving Biotech. Berenbaum is also a Scientific Advisory Board member at Peptinov and has been Président d'Honneur of the Société Française de Rhumatologie since March 2017. Additionally, Berenbaum is a Senior Associate Editor for the BMJ Annals of the Rheumatic Diseases and an Advisory Board Member for Nature Reviews Rheumatology. Berenbaum practices as a rheumatologist at APHP - Hopital Saint-Antoine and leads a research team focused on age-related joint diseases and metabolism at INSERM. Educational credentials include a role as professeur en médecine, rhumatologie at Sorbonne Université and a Doctorate in medicine from Pierre and Marie Curie University. Berenbaum was previously President of the French Society of Rheumatology from February 2015 to February 2017 and participated in the HEC Challenge + program at HEC Paris in 2022.